Search research articles
Contact Us
Filters
Showing results (211-220 of 338) with videos related to
Page
of 34
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
October 27, 2009
CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose
Amarjit S Chaudhry, Thomas J Urban, Jatinder K Lamba, et al.
Nature Genetics
|
December 21, 2004
A single-nucleotide polymorphism tagging set for human drug metabolism and transport
Kourosh R Ahmadi, Mike E Weale, Zhengyu Y Xue, et al.
Plos Genetics
|
November 30, 2017
A case-control collapsing analysis identifies epilepsy genes implicated in trio sequencing studies focused on de novo mutations
Xiaolin Zhu, Raghavendra Padmanabhan, Brett Copeland, et al.
American Journal of Human Genetics
|
September 4, 2012
Using ERDS to infer copy-number variants in high-coverage genomes
Mingfu Zhu, Anna C Need, Yujun Han, et al.
The Lancet. Neurology
|
April 18, 2014
Distinct neurological disorders with ATP1A3 mutations
Erin L Heinzen, Alexis Arzimanoglou, Allison Brashear, et al.
Plos Genetics
|
October 2, 2023
Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency
Sarah A Dugger, Ryan S Dhindsa, Gabriela De Almeida Sampaio, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2011
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response
Jama M Darling, Jeroen Aerssens, Gregory Fanning, et al.
Hepatology (Baltimore, Md.)
|
January 29, 2011
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR
Alexander J Thompson, Rosanna Santoro, Valeria Piazzolla, et al.
Frontiers in Cellular Neuroscience
|
June 5, 2023
Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitor
Sophie Colombo, Haritha P Reddy, Sabrina Petri, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 7, 2015
TECPR2 mutations cause a new subtype of familial dysautonomia like hereditary sensory autonomic neuropathy with intellectual disability
Gali Heimer, Danit Oz-Levi, Eran Eyal, et al.
Page
of 34
Search research articles
Search
Showing results (211-220 of 338) with videos related to
Sort By:
Page
of 34
The Journal of Pharmacology and Experimental Therapeutics
|
October 27, 2009
CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose
Amarjit S Chaudhry, Thomas J Urban, Jatinder K Lamba, et al.
Nature Genetics
|
December 21, 2004
A single-nucleotide polymorphism tagging set for human drug metabolism and transport
Kourosh R Ahmadi, Mike E Weale, Zhengyu Y Xue, et al.
Plos Genetics
|
November 30, 2017
A case-control collapsing analysis identifies epilepsy genes implicated in trio sequencing studies focused on de novo mutations
Xiaolin Zhu, Raghavendra Padmanabhan, Brett Copeland, et al.
American Journal of Human Genetics
|
September 4, 2012
Using ERDS to infer copy-number variants in high-coverage genomes
Mingfu Zhu, Anna C Need, Yujun Han, et al.
The Lancet. Neurology
|
April 18, 2014
Distinct neurological disorders with ATP1A3 mutations
Erin L Heinzen, Alexis Arzimanoglou, Allison Brashear, et al.
Plos Genetics
|
October 2, 2023
Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency
Sarah A Dugger, Ryan S Dhindsa, Gabriela De Almeida Sampaio, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2011
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response
Jama M Darling, Jeroen Aerssens, Gregory Fanning, et al.
Hepatology (Baltimore, Md.)
|
January 29, 2011
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR
Alexander J Thompson, Rosanna Santoro, Valeria Piazzolla, et al.
Frontiers in Cellular Neuroscience
|
June 5, 2023
Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitor
Sophie Colombo, Haritha P Reddy, Sabrina Petri, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 7, 2015
TECPR2 mutations cause a new subtype of familial dysautonomia like hereditary sensory autonomic neuropathy with intellectual disability
Gali Heimer, Danit Oz-Levi, Eran Eyal, et al.
Page
of 34